KR101882087B1 - 어류 바이러스성 출혈성 패혈증 바이러스에 특이적인 단클론항체 및 이의 용도 - Google Patents

어류 바이러스성 출혈성 패혈증 바이러스에 특이적인 단클론항체 및 이의 용도 Download PDF

Info

Publication number
KR101882087B1
KR101882087B1 KR1020160108260A KR20160108260A KR101882087B1 KR 101882087 B1 KR101882087 B1 KR 101882087B1 KR 1020160108260 A KR1020160108260 A KR 1020160108260A KR 20160108260 A KR20160108260 A KR 20160108260A KR 101882087 B1 KR101882087 B1 KR 101882087B1
Authority
KR
South Korea
Prior art keywords
septisemia
virus
monoclonal antibody
antibody against
against viral
Prior art date
Application number
KR1020160108260A
Other languages
English (en)
Other versions
KR20180023248A (ko
Inventor
김위식
오명주
김종오
장민석
정하나
Original Assignee
전남대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 전남대학교산학협력단 filed Critical 전남대학교산학협력단
Priority to KR1020160108260A priority Critical patent/KR101882087B1/ko
Publication of KR20180023248A publication Critical patent/KR20180023248A/ko
Application granted granted Critical
Publication of KR101882087B1 publication Critical patent/KR101882087B1/ko

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/145—Rhabdoviridae, e.g. rabies virus, Duvenhage virus, Mokola virus or vesicular stomatitis virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/4603—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates from fish

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
KR1020160108260A 2016-08-25 2016-08-25 어류 바이러스성 출혈성 패혈증 바이러스에 특이적인 단클론항체 및 이의 용도 KR101882087B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160108260A KR101882087B1 (ko) 2016-08-25 2016-08-25 어류 바이러스성 출혈성 패혈증 바이러스에 특이적인 단클론항체 및 이의 용도

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160108260A KR101882087B1 (ko) 2016-08-25 2016-08-25 어류 바이러스성 출혈성 패혈증 바이러스에 특이적인 단클론항체 및 이의 용도

Publications (2)

Publication Number Publication Date
KR20180023248A KR20180023248A (ko) 2018-03-07
KR101882087B1 true KR101882087B1 (ko) 2018-07-25

Family

ID=61688772

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160108260A KR101882087B1 (ko) 2016-08-25 2016-08-25 어류 바이러스성 출혈성 패혈증 바이러스에 특이적인 단클론항체 및 이의 용도

Country Status (1)

Country Link
KR (1) KR101882087B1 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102034609B1 (ko) * 2019-04-12 2019-10-21 대한민국 바이러스성 출혈성 패혈증 바이러스에 특이적으로 결합하는 단클론 항체를 포함하는 바이러스성 출혈성 패혈증 바이러스 검출용 조성물

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102163241B1 (ko) 2018-06-05 2020-10-08 전남대학교산학협력단 돌돔의 면역글로불린 m에 특이적인 단클론 항체 및 이의 용도
KR102163242B1 (ko) 2018-06-05 2020-10-08 전남대학교산학협력단 무지개송어의 면역글로불린 m에 특이적인 단클론항체 및 이의 용도
KR20190138607A (ko) 2018-06-05 2019-12-13 전남대학교산학협력단 잉어봄바이러스에 특이적인 단클론항체 및 이의 용도
KR102025079B1 (ko) * 2019-04-12 2019-09-25 대한민국 고병원성 바이러스성출혈성패혈증 바이러스 검출용 조성물 및 이를 이용한 바이러스성출혈성패혈증 바이러스의 검출방법
KR102281658B1 (ko) * 2021-04-02 2021-07-26 제주대학교 산학협력단 넙치의 바이러스성 출혈성 패혈증 바이러스 저항성 예측용 snp 마커 및 이의 용도
KR102384570B1 (ko) * 2021-11-30 2022-04-08 전남대학교산학협력단 넙치랩도바이러스병 감염 여부 현장검사 진단키트용 검체시료조성물 및 상기 조성물을 이용한 넙치랩도바이러스병 현장진단방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011046193A1 (ja) * 2009-10-16 2011-04-21 国立大学法人東京海洋大学 ウイルス性出血性敗血症ウイルス結合性アプタマー
CN202404102U (zh) * 2011-11-10 2012-08-29 鲁东大学 鱼类病毒性出血性败血症病毒快速检测试纸
KR101642784B1 (ko) * 2016-01-15 2016-07-27 대한민국 바이러스성 출혈성 패혈증 바이러스 판별용 유전자 마커, 및 이를 이용한 원인바이러스의 판별방법

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102034609B1 (ko) * 2019-04-12 2019-10-21 대한민국 바이러스성 출혈성 패혈증 바이러스에 특이적으로 결합하는 단클론 항체를 포함하는 바이러스성 출혈성 패혈증 바이러스 검출용 조성물

Also Published As

Publication number Publication date
KR20180023248A (ko) 2018-03-07

Similar Documents

Publication Publication Date Title
HK1247213A1 (zh) Pd-l1抗體、其抗原結合片段及其醫藥用途
EP3504243A4 (en) ANTI-TIM-3 ANTIBODIES AND USE THEREOF
EP3572427A4 (en) BCMA TARGETING ANTIBODIES AND ITS USE
EP3473649A4 (en) MONOCLONAL ANTI-CD47 ANTIBODIES AND USES THEREOF
EP3523332A4 (en) ANTI-4-1 BB HUMAN ANTIBODIES AND USE THEREOF
EP3411071A4 (en) NOVEL MONOCLONAL ANTIBODIES ANTI-CD 47 AND USES THEREOF
KR101882087B1 (ko) 어류 바이러스성 출혈성 패혈증 바이러스에 특이적인 단클론항체 및 이의 용도
EP3426288A4 (en) ANTI-PACAP ANTIBODIES AND USES THEREOF
EP3181587A4 (en) Anti-human il-17 monoclonal antibody and use thereof
EP3606555A4 (en) INFLUENZA VIRUS TYPE B ANTI-NEURAMINIDASE ANTIBODIES AND THEIR USES
EP3274051A4 (en) Multi-valent hepatitis b virus antigen binding molecules and uses thereof
EP3442567A4 (en) ANTI-PSMA ANTIBODIES AND THEIR USE
IL284044A (en) Antibodies that neutralize the hepatitis B virus and their uses
EP3567054A4 (en) ANTI-ALPHA SYN ANTIBODIES AND USES THEREOF
HK1246805A1 (zh) 抗flu b的廣譜單克隆抗體及其用途
EP3464355A4 (en) MONOCLONAL DSG2 ANTIBODIES AND USES THEREOF
AU2017271189A1 (en) Cytosol-penetrating antibody and use thereof
EP3529273A4 (en) ANTI-O1 ANTIBODIES AND USES THEREOF
EP3448892A4 (en) HUMANIZED ANTI-BASIGIN ANTIBODIES AND USES THEREOF
EP3455261A4 (en) ANTI-ROR2 ANTIBODIES, ANTIBODY FRAGMENTS, THEIR IMMUNOCONJUGATES AND USES THEREOF
EP3496748A4 (en) ANTI-O2 ANTIBODIES AND USES THEREOF
EP3699193A4 (en) ANTI-VISTA ANTIBODIES AND USE THEREOF
EP3412688A4 (en) THROMBIN ANTIBODY, ANTIGENBINDING FRAGMENT, AND PHARMACEUTICAL USE THEREOF
EP3601361A4 (en) ANTI-CEACAM1 ANTIBODIES AND USES THEREOF
EP3545000A4 (en) ANTI-CD300F ANTIBODIES AND USES THEREOF

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant